The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Atyr Pharma Inc (NASDAQ: ATYR) closed at $3.32 up 2.00% from its previous closing price of $3.25. In other words, the price has increased by $2.00 from its previous closing price. On the day, 2.31 million shares were traded. ATYR stock price reached its highest trading level at $3.36 during the session, while it also had its lowest trading level at $3.13.
Ratios:
For a deeper understanding of Atyr Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.63 and its Current Ratio is at 7.63. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.16.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on October 04, 2024, initiated with a Overweight rating and assigned the stock a target price of $17.
On September 05, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 24 ’24 when SCHIMMEL PAUL bought 52,300 shares for $1.93 per share. The transaction valued at 101,038 led to the insider holds 413,023 shares of the business.
SCHIMMEL PAUL bought 41,052 shares of ATYR for $71,500 on Jul 22 ’24. The Director now owns 354,075 shares after completing the transaction at $1.74 per share. On Jul 23 ’24, another insider, SCHIMMEL PAUL, who serves as the Director of the company, bought 6,648 shares for $1.82 each. As a result, the insider paid 12,075 and bolstered with 360,723 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATYR now has a Market Capitalization of 251264400 and an Enterprise Value of 186449392. For the stock, the TTM Price-to-Sale (P/S) ratio is 425.89 while its Price-to-Book (P/B) ratio in mrq is 3.08. Its current Enterprise Value per Revenue stands at 317.091 whereas that against EBITDA is -3.016.
Stock Price History:
Over the past 52 weeks, ATYR has reached a high of $3.54, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is 56.92%, while the 200-Day Moving Average is calculated to be 78.95%.
Shares Statistics:
For the past three months, ATYR has traded an average of 678.11K shares per day and 1686880 over the past ten days. A total of 75.80M shares are outstanding, with a floating share count of 73.81M. Insiders hold about 2.61% of the company’s shares, while institutions hold 70.14% stake in the company. Shares short for ATYR as of 1728950400 were 1065364 with a Short Ratio of 1.57, compared to 1726185600 on 685779. Therefore, it implies a Short% of Shares Outstanding of 1065364 and a Short% of Float of 1.91.
